Post-earnings recap
Reported
Mon, Feb 10, 2025
EPS actual
$-1.39
EPS est.
$-0.42
EPS surprise
-231.74%
1-day move
-1.58%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Arrowhead Pharmaceuticals reported a significant loss per share of $-1.39, which was a notable miss. The stock reacted negatively, declining by 1.58%. The lack of revenue data and management commentary leaves investors without further context on the company's performance and future outlook.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-1.39 | N/A | -231.74% |
| Revenue | — | N/A | — |
No transcript is on record for this earnings call, so the analysis is based solely on the numerical results.